Y

ou, the readers of STAT, have spoken. Your votes determined the best and worst biopharma CEOs of 2017.

The Best: John Maraganore of Alnylam Pharmaceuticals. Congratulations, John!

This is a STAT Plus article and you can unlock it by subscribing to STAT Plus today. It's easy! Your first 30 days are free and if you don't enjoy your subscription you can cancel any time.
Already a subscriber? Log in here.

Leave a Comment

Please enter your name.
Please enter a comment.

  • Hi, Adam. I have followed STAT’s reports on Dr. Soon-Shiong. As a former journalist, I am appalled that he has just bought the LA Times. The horse is probably out of the barn on that sale. But I’m wondering if you guys are planning to circle back and update the tale of his health care boondoggles….

Sign up for our Morning Rounds newsletter

Your daily dose of what’s new in health and medicine.